Comprehensive Landscape of Extracellular Vesicle-derived RNAs in Cancer Initiation, Progression, Metastasis and Cancer Immunology
Overview
Oncology
Authors
Affiliations
Extracellular vesicles (EVs), a class of heterogeneous membrane vesicles, are generally divided into exosomes and microvesicles on basis of their origination from the endosomal membrane or the plasma membrane, respectively. EV-mediated bidirectional communication among various cell types supports cancer cell growth and metastasis. EVs derived from different cell types and status have been shown to have distinct RNA profiles, comprising messenger RNAs and non-coding RNAs (ncRNAs). Recently, ncRNAs have attracted great interests in the field of EV-RNA research, and growing numbers of ncRNAs ranging from microRNAs to long ncRNAs have been investigated to reveal their specific functions and underlying mechanisms in the tumor microenvironment and premetastatic niches. Emerging evidence has indicated that EV-RNAs are essential functional cargoes in modulating hallmarks of cancers and in reciprocal crosstalk within tumor cells and between tumor and stromal cells over short and long distance, thereby regulating the initiation, development and progression of cancers. In this review, we discuss current findings regarding EV biogenesis, release and interaction with target cells as well as EV-RNA sorting, and highlight biological roles and molecular mechanisms of EV-ncRNAs in cancer biology.
Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells.
Balaraman A, Babu M, Afzal M, Sanghvi G, M M R, Gupta S Regen Ther. 2025; 28:558-572.
PMID: 40034540 PMC: 11872554. DOI: 10.1016/j.reth.2025.01.019.
The role of RNA structural motifs in RNA-lipid raft interaction.
Manka R, Sapon K, Zaziablo J, Janas T, Czogalla A, Janas T Sci Rep. 2025; 15(1):6777.
PMID: 40000734 PMC: 11861254. DOI: 10.1038/s41598-025-91093-x.
Quan J, Liu Q, Li P, Yang Z, Zhang Y, Zhao F Stem Cell Res Ther. 2025; 16(1):76.
PMID: 39985030 PMC: 11846194. DOI: 10.1186/s13287-025-04160-5.
Jiang X, Qu A, Zhang S, Jin S, Wang L, Zhang Y Front Oncol. 2024; 14:1451009.
PMID: 39737397 PMC: 11683095. DOI: 10.3389/fonc.2024.1451009.
Cao Y, Xia J, Li L, Zeng Y, Zhao J, Li G JACS Au. 2024; 4(12):4655-4672.
PMID: 39735934 PMC: 11672140. DOI: 10.1021/jacsau.4c00989.